Abstract
The mammalian fatty acid-binding proteins (FABPs) are thought to be important for the transport and metabolism of fatty acids in numerous cell types. The transfer of FA from different members of the FABP family to membranes has been shown to occur by two distinct mechanisms, an aqueous diffusion-based mechanism and a collisional mechanism, wherein the FABP interacts directly with membrane acceptors. Much of the work that underlies this concept comes from efforts using rodent FABPs. Given the increasing awareness of links between FABPs and several chronic diseases in humans, it was important to establish the mechanisms of FA transfer for human FABPs. In the present studies, we examined the rate and mechanism of fatty acid transfer from four pairs of human and rodent (rat or mouse, as specified) FABPs: hLFABP and rLFABP, hIFABP and rIFABP, hHFABP and rHFABP, and hAFABP and mAFABP. In the case of human IFABP, both the Ala54 and Thr54 forms were examined. The results show clearly that for all FABPs examined, the mechanisms of ligand transfer observed for rodent proteins hold true for their human counterparts. Moreover, it appears that the Ala to Thr substitution at residue 54 of the human IFABP does not alter the fundamental mechanism of ligand transfer to membranes, but nevertheless causes a consistent decrease in the rate of transfer.
Similar content being viewed by others
References
Storch J, Thumser AEA: The fatty acid transport function of fatty acidbinding proteins. Biochim Biophys Acta 1486: 28–44, 2000
Glatz JFC, van der Vusse G: Cellular fatty acid-binding proteins: Their function and physiological significance. Prog Lipid Res 35: 243–282, 1996
Kim HK, Storch J: Free fatty acid transfer from rat liver fatty acidbinding protein to phospholipid vesicles: Effect of ligand and solution properties. J Biol Chem 267: 77–82, 1992
Hsu KT, Storch J: Fatty acid transfer from liver and intestinal fatty acid binding-proteins to membranes occurs by different mechanisms. J Biol Chem 271: 13317–13323, 1996
Storch J, Bass NM: Transfer of fluorescent fatty acids from liver and heart fatty acid-binding proteins to model membranes. J Biol Chem 265: 7827–7831, 1990
Wootan MG, Bernlohr DA, Storch J: Mechanism of fluorescent fatty acid transfer from adipocyte fatty acid binding protein to membrane. Biochemistry 32: 8622–8627, 1993
Wootan MG, Storch J: Regulation of fluorescent fatty acid transfer from adipocyte and heart fatty acid binding proteins by acceptor membrane lipid composition and structure. J Biol Chem 269: 10517–10523, 1994
Kim HK, Storch J: Mechanism of free fatty acid transfer from rat heart fatty acid binding protein to phospholipid membranes: Evidence for a collisional process. J Biol Chem 267: 20051–20056, 1992
Liou H, Storch J: The helical cap domain is important for fatty acid transfer from adipocyte and heart fatty acid-binding proteins to membranes. FASEB J 12: A514, 1998
Corsico B, Cistola DP, Frieden C, Storch J: The helical domain of intestinal fatty acid binding protein is critical for collisional transfer of fatty acids to phospholipid membranes. Proc Natl Acad Sci USA 95: 12174–12178, 1998
Liou H-L, Storch J: Role of surface lysine residues of adipocyte fatty acid-binding protein in fatty acid transfer to phospholipid vesicles. Biochemistry 40: 6475–6485, 2001
Richieri GV, Low PJ, Ogata RT, Kleinfeld AM: Thermodynamics of fatty acid binding to engineered mutants of the adipocyte and intestinal fatty acid-binding proteins. J Biol Chem 273: 7397–7405, 1998
Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281–1287, 1995
Herr FM, Matarese V, Bernlohr DA, Storch J: Surface lysine residues modulate the collisional transfer of fatty acid from adipocyte fatty acid binding protein to membranes. Biochemistry 34: 11840–11845, 1995
Zimmerman AW, van Moerkerk HTB, Veerkamp JH: Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol 33: 865–876, 2001
Veerkamp JH, van Moerkerk HTB, Prinsen CFM, van Kuppevelt TH: Structural and functional studies on different human FABP types. Mol Cell Biochem 192: 137–142, 1999
Smith ER, Storch J: The adipocyte fatty acid-binding protein binds to membranes by electrostatic interactions. J Biol Chem 274: 35325–35330, 1999
Ames BN: Assay of inorganic phosphate, total phosphate and phosphatases. Meth Enzymol 8: 115–118, 1966
Herr FM, Aronson J, Storch J: Role of portal region lysine residues in electrostatic interactions between heart fatty acid binding protein and phospholipid membranes. Biochemistry 35: 1296–1303, 1996
Richieri GV, Ogata RT, Kleinfeld AM: Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 269: 23918–23930, 1994
Charlton SC, Smith LC: Kinetics of transfer of pyrene and rac-1-oleyl-2-[4-(3-pyrenyl)butanoyl]glycerol between human plasma lipoproteins. Biochemistry 21: 4023–4030, 1982
Zucker SD: Kinetic model of protein-mediated ligand transport: Influence of soluble binding proteins on the intermembrane diffusion of a fluorescent fatty acid. Biochemistry 40: 977–986, 2001
Weisiger RW, Zucker SD: Transfer of fatty acids between intracellular membranes: Roles of soluble binding proteins, distance, and time. Am J Physiol 282: G105–G115, 2002
Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L, Ravussin E, Bogardus C: Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 41: 2002–2008, 2000
Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI: Postprandial responses of individual fatty acids in subjects homozygous for the threonine-or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 73: 31–35, 2001
Georgopoulos A, Aras O, Tsai MY: Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 85: 3155–3160, 2000
Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL: Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in africanamericans: The atherosclerosis risk in communities study. Diabetes 48: 1868–1872, 1999
Tahvanainen E, Molin M, Vainio S, Tiret L, Nicaud V, Farinaro E, Masana L, Ehnholm C: Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young europeans. Results from EARS II participants. Atherosclerosis 152: 317–325, 2000
Levy E, Menard D, Delvin E, Stan S, Mitchell G, Lambert M, Ziv E, Feoli-Fonseca JC, Seidman E: The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 276: 39679–39684, 2001
Vassileva G, Huwyler L, Poirier K, Agellon LBTMJ: The intestinal fatty acid binding protein is not essential for dietary fat absorption in mice. FASEB J 14: 2040–2046, 2000
Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271: 10892–10896, 1996
Darimont C, Gradoux N, Persohn E, Cumin F, De Pover A: Effects of intestinal fatty acid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. J Lipid Res 41: 84–92, 2000
Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ: Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13: 805–812, 1999
Scheja L, Makowski L, Uysal KT, Wiesbrock SM, Shimshek DR, Meyers DS, Morgan M, Parker RA, Hotamisligil GS: Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 48: 1987–1993, 1999
Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS: Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388–3396, 2000
Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK: Adipocyte metabolism in adipocyte fatty acid binding protein knockout (aP2-/-) mice after short-term high-fat feeding. Diabetes 49: 904–911, 2000
Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377–1379, 1996
Coe NR, Simpson MA, Bernlohr D: Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 40: 967–972, 1999
Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME: Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J. 15: 1774–1776, 2001
Layne MD, Patel A, Chen YH, Rebel VI, Carvajal IM, Pellacani A, Ith B, Zhao D, Schreiber BM, Yet SF, Lee ME, Storch J, Perrella MA: Role of macrophage-expressed adipocyte fatty acid-binding protein in the development of accelerated atherolsclerosis in hypercholesterolemic mice. FASEB J 15: 2733–3735, 2001
Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nature Med 7: 699–705, 2001
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Storch, J., Veerkamp, J.H. & Hsu, KT. Similar mechanisms of fatty acid transfer from human anal rodent fatty acid-binding proteins to membranes: Liver, intestine, heart muscle, and adipose tissue FABPs. Mol Cell Biochem 239, 25–33 (2002). https://doi.org/10.1023/A:1020546321508
Issue Date:
DOI: https://doi.org/10.1023/A:1020546321508